Algorithms and criteria for transcatheter aortic valve replacement patient selection: Current status and future trends

Current Pharmaceutical Design

Volumn 22, Issue 13, 2016, Pages 1862-1867

  Lilly, Scott M ^a   Abraham, William T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Aortic stenosis; Aortic valve replacement; Frailty; Multi disciplinary; Patient selection; Risk assessment

Indexed keywords

ALGORITHM; AORTA STENOSIS; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; HUMAN; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATIENT ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; ADVERSE EFFECTS; AORTIC VALVE STENOSIS;

ALGORITHMS; AORTIC VALVE STENOSIS; HUMANS; PATIENT SELECTION; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84964273488     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612822666151208121437     Document Type: Article

References (60)

1. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Eng J Med 2010; 363(17): 1597-607.
2. Ross J, Jr., Braunwald E. Aortic stenosis. Circulation 1968; 38(1 Suppl): 61-7.
3. Kvidal P, Bergstrom R, Horte LG, Stahle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000; 35(3): 747-56.
4. Connolly HM, Oh JK, Orszulak TA, et al. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Prognostic indicators. Circulation 1997; 95(10): 2395-400.
5. Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol 2007; 50(20): 2018-9.
6. Bouma BJ, van Den Brink RB, van Der Meulen JH, et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart 1999; 82(2): 143-8.
7. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Eng J Med 2011; 364(23): 2187-98.
8. Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385(9986): 2477-84.
9. Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385(9986): 2485-91.
10. Adams DH, Popma JJ, Reardon MJ. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Eng J Med 2014; 371(10): 967-8.
11. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Eng J Med 2012; 366(18): 1705-15.
12. Mohr FW, Holzhey D, Mollmann H, et al. The german aortic valve registry: 1-year results from 13,680 patients with aortic valve disease. Eur J Cardiothorac Surg 2014; 46(5): 808-16.
13. D'Errigo P, Barbanti M, Ranucci M, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: Results from an intermediate risk propensitymatched population of the Italian Observant study. Int J Cardiol 2013; 167(5): 1945-52.
14. Jilaihawi H, Chakravarty T, Weiss RE, Fontana GP, Forrester J, Makkar RR. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Catheter Cardiovasc Interv 2012; 80(1): 128-38.
15. Nazif TM, Dizon JM, Hahn RT, et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. Cardiovasc Interv 2015; 8(1 Pt A): 60-9.
16. Erkapic D, De Rosa S, Kelava A, Lehmann R, Fichtlscherer S, Hohnloser SH. Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovas Electrophysiol 2012; 23(4): 391-7.
17. Pendyala LK, Minha S, Barbash IM, et al. Commercial versus PARTNER study experience with the transfemoral Edwards SAPIEN valve for inoperable patients with severe aortic stenosis. Am J Cardiol 2014; 113(2): 342-7.
18. Khatri PJ, Webb JG, Rodes-Cabau J, et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Internal Med 2013; 158(1): 35-46.
19. Ledwoch J, Franke J, Gerckens U, et al. Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: analysis from the German transcatheter aortic valve interventions registry. Catheter Cardiovasc Interv 2013; 82(4): E569-77.
20. Urena M, Webb JG, Tamburino C, et al. Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation 2014; 129(11): 1233-43.
21. Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol 2013; 61(15): 1585-95.
22. Nishimura RA, Otto CM, Bonow RO, et al 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the Am College Cardiol/American Heart Association Task Force on Practice Guidelines. J Thoracic Cardiovasc Surg 2014; 148(1): e1-e132.
23. Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, Vahanian A, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33(19): 2451-96.
24. Thyregod HG, Steinbruchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-Year results from the all-comers notion randomized clinical trial. J Am Coll Cardiol 2015; 65(20): 2184-94.
25. Reynolds MR, Magnuson EA, Lei Y, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am College Cardiol 2012; 60(25): 2683-92.
26. Simons CT, Cipriano LE, Shah RU, Garber AM, Owens DK, Hlatky MA. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a costeffectiveness analysis. Circ Cardiovasc Qual Outcomes 2013; 6(4): 419-28.
27. Reynolds MR, Cohen DJ. The cost-effectiveness of transcatheter aortic valve replacement for nonsurgical candidates: revisionist history or the final word? Circ Cardiovasc Qual Outcomes 2013; 6(4): 376-8.
28. Pibarot P, Dumesnil JG. Improving assessment of aortic stenosis. J Am Coll Cardiol 2012; 60(3): 169-80.
29. Nishimura RA, Carabello BA. Hemodynamics in the cardiac catheterization laboratory of the 21st century. Circulation 2012; 125(17): 2138-50.
30. Dewey TM, Brown DL, Herbert MA, et al. Effect of concomitant coronary artery disease on procedural and late outcomes of tran scatheter aortic valve implantation. Ann Thoracic Surg 2010; 89(3): 758-67; discussion 67.
31. Genereux P, Webb JG, Svensson LG, et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol 2012; 60(12): 1043-52.
32. Hayashida K, Lefevre T, Chevalier B, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interven 2011; 4(8): 851-8.
33. Krishnaswamy A, Parashar A, Agarwal S, et al. Predicting vascular complications during transfemoral transcatheter aortic valve replacement using computed tomography: a novel area-based index. Catheter Cardiovasc Interv 2014; 84(5): 844-51.
34. Messika-Zeitoun D, Serfaty JM, Brochet E, et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol 2010; 55(3): 186-94.
35. Genereux P, Head SJ, Hahn R, et al. Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature. J Am Coll Cardiol 2013; 61(11): 1125-36.
36. Leipsic J, Gurvitch R, Labounty TM, et al. Multidetector computed tomography in transcatheter aortic valve implantation. JACC Cardiovasc Imaging 2011; 4(4): 416-29.
37. Durand E, Borz B, Godin M, et al. Performance analysis of Euro-SCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 2013; 111(6): 891-7.
38. Melby SJ, Moon MR, Lindman BR, Bailey MS, Hill LL, Damiano RJ, Jr. Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thoracic Cardiovasc Surg 2011; 141(6): 1424-30.
39. Arnold SV, Reynolds MR, Lei Y, et al. Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial. Circulation 2014; 129(25): 2682-90.
40. Green P, Woglom AE, Genereux P, et al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. Cardiovasc Interven 2012; 5(9): 974-81.
41. Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist 1970; 10(1): 20-30.
42. Sundermann S, Dademasch A, Praetorius J, et al. Comprehensive assessment of frailty for elderly high-risk patients undergoing cardiac surgery. Eur J Cardiothorac Surg 2011; 39(1): 33-7.
43. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol Ser A Biol Sci Med Sci 2004; 59(3): 255-63.
44. Dvir D, Waksman R, Barbash IM, et al. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve). J Am Coll Cardiol 2014; 63(3): 269-79.
45. Sinning JM, Ghanem A, Steinhauser H, et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. Cardiovasc Interven 2010; 3(11): 1141-9.
46. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Eng J Med 2012; 366(18): 1686-95.
47. Toggweiler S, Boone RH, Rodes-Cabau J, et al. Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation. J Am Coll Cardiol 2012; 59(23): 2068-74.
48. Stortecky S, Schoenenberger AW, Moser A, et al. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. Cardiovasc Interven 2012; 5(5): 489-96.
49. Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010; 55(11): 1080-90.
50. Shreenivas SS, Lilly SM, Szeto WY, et al. Cardiopulmonary bypass and intra-aortic balloon pump use is associated with higher short and long term mortality after transcatheter aortic valve replacement: A PARTNER trial substudy. Catheter Cardiovasc Interv 2015; 86(2): 316-22.
51. Thourani VH, Li C, Devireddy C, et al. High-risk patients with inoperative aortic stenosis: use of transapical, transaortic, and transcarotid techniques. Ann Thoracic Surg 2015; 99(3): 817-25.
52. Capodanno D, Barbanti M, Tamburino C, et al. A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 2014; 113(11): 1851-8.
53. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the kansas city cardiomyopathy questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 2000; 35(5): 1245-55.
54. Consensus statement of the Society of Critical Care Medicine's Ethics Committee regarding futile and other possibly inadvisable treatments. Crit Care Med 1997; 25(5): 887-91.
55. Withholding and withdrawing life-sustaining therapy. This official statement of the american thoracic society was adopted by the ATS Board of Directors, March 1991. Am Rev Respiratory Dis 1991; 144(3 Pt 1): 726-31.
56. McDermid RC, Bagshaw SM. Prolonging life and delaying death: the role of physicians in the context of limited intensive care resources. Philos Ethics Human Med PEHM 2009; 4: 3.
57. Mack MJ, Holmes DR, Webb J, et al. Patient selection for transcatheter aortic valve replacement. J Am Coll Cardiol 2013; 62(17 Suppl): S1-10.
58. Holmes DR, Jr., Mack MJ, Kaul S, et al 2012 ACCF/AATS/ SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 2012; 59(13): 1200-54.
59. Hawkey MC, Lauck SB, Perpetua EM, et al. Transcatheter aortic valve replacement program development: recommendations for best practice. Catheter Cardiovasc Interv 2014; 84(6): 859-67.
60. Sintek M, Zajarias A. Patient evaluation and selection for transcatheter aortic valve replacement: the heart team approach. Prog Cardiovas Dis 2014; 56(6): 572-82.